Abemaciklib (Slovenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Abemaciklib" in Slovenian language version.

refsWebsite

Global rank Slovenian rank

68^th place

28^th place

4^th place

8^th place

low place

low place

2^nd place

5^th place

447^th place

409^th place

399^th place

169^th place

1s3-us-west-2.amazonaws.com

low place

low place

doi.org

Lu J (Avgust 2015). »Palbociclib: a first-in-class CDK4/CDK6 inhibitor for the treatment of hormone-receptor positive advanced breast cancer«. Journal of Hematology & Oncology. 8 (1): 98. doi:10.1186/s13045-015-0194-5. PMC 4534142. PMID 26264704.

drugs.com

Drugs.com: Abemaciclib monograph. Dostop: 12. 11. 2017.

europa.eu

ema.europa.eu

https://www.ema.europa.eu/en/documents/product-information/verzenios-epar-product-information_sl.pdf Povzetek glavnih značilnosti zdravila Verzenios, vpogled: 7. 11. 2022.
https://www.ema.europa.eu/en/medicines/human/EPAR/verzenios, vpogled: 8. 11. 2022.
https://www.ema.europa.eu/en/documents/overview/verzenios-epar-medicine-overview_sl.pdf Verzenios (abemaciklib) – Pregled zdravila Verzenios in zakaj je odobreno v EU, Evropska agencija za zdravila, vpogled: 8. 11. 2022.

fda.gov

»FDA approves new treatment for certain advanced or metastatic breast cancers« (tiskovna objava). Urad za prehrano in zdravila. 28. september 2017.

hres.ca

hpr-rps.hres.ca

»Summary Basis of Decision (SBD) for Verzenio«. Health Canada. 23. oktober 2014. Pridobljeno 29. maja 2022.

nih.gov

ncbi.nlm.nih.gov

Lu J (Avgust 2015). »Palbociclib: a first-in-class CDK4/CDK6 inhibitor for the treatment of hormone-receptor positive advanced breast cancer«. Journal of Hematology & Oncology. 8 (1): 98. doi:10.1186/s13045-015-0194-5. PMC 4534142. PMID 26264704.

pubmed.ncbi.nlm.nih.gov

Lu J (Avgust 2015). »Palbociclib: a first-in-class CDK4/CDK6 inhibitor for the treatment of hormone-receptor positive advanced breast cancer«. Journal of Hematology & Oncology. 8 (1): 98. doi:10.1186/s13045-015-0194-5. PMC 4534142. PMID 26264704.

s3-us-west-2.amazonaws.com

»Highlights of Prescribing Information for Verzenio« (PDF). september 2017.{{navedi splet}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)